GCP
REPL icon

GSA Capital Partners’s Replimune Group REPL Stock Holding History

GSA Capital Partners’s Portfolio REPL Stock Details REPL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-29,147
Closed -$283K – 2091
2025
Q4 		$283K Buy
29,147
+9,861
+51% +$83.8K 0.02% 1200
2025
Q3 		$81K Buy
+19,286
New +$123K 0.01% 1542
2024
Q4 		– Sell
-20,254
Closed -$222K – 1960
2024
Q3 		$222K Buy
+20,254
New +$206K 0.02% 1375
2023
Q2 		– Sell
-23,642
Closed -$418K – 1874
2023
Q1 		$418K Buy
+23,642
New +$562K 0.04% 824
2022
Q3 		– Sell
-59,430
Closed -$1.04M – 1807
2022
Q2 		$1.04M Sell
59,430
-27,694
-32% -$455K 0.16% 132
2022
Q1 		$1.48M Buy
+87,124
New +$1.64M 0.2% 63
2021
Q2 		– Sell
-7,369
Closed -$225K – 1554
2021
Q1 		$225K Buy
+7,369
New +$276K 0.04% 827

Other funds holding REPL

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FIS
FCPM III Services Naarden, Netherlands $722M AUM 73.61% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

GSA Capital Partners's REPL Position: Q1 2026 in Review

GSA Capital Partners sold out of Replimune Group (REPL) in Q1 2026, closing a stake of 29,147 shares — an estimated $283K sold.

GSA Capital Partners first reported a position in REPL in Q1 2021 and held it in 7 quarters. The position peaked at $1.48M in Q1 2022. 180 funds tracked by Wall St. Rank hold REPL as of Q1 2026.

  • GSA Capital Partners reported no remaining Replimune Group position as of Q1 2026 after selling out during the quarter.
  • GSA Capital Partners sold 29,147 Replimune Group shares in Q1 2026, an estimated $283K.
  • GSA Capital Partners first reported a position in Replimune Group in Q1 2021 and held it in 7 quarters.
  • GSA Capital Partners's Replimune Group position peaked at $1.48M in Q1 2022.
  • 180 funds tracked by Wall St. Rank held Replimune Group as of Q1 2026.

Based on GSA Capital Partners's 13F filing for Q1 2026, filed 8 May 2026.